Healthcare Innovation

Actiphy's new ImageReplicator strengthens cyber resilience with immutable backups and automated replication, shielding critical data from escalating ransomware threats.

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

The journey from brand launch to retail shelf has shrunk from years to just 18 months. A new playbook reveals how TikTok data and GLP-1 drugs are the forces behind this massive shift.

Boy George's 'Karma Chameleon' gets an AI-assisted update. A new model from Syntiant and Artist Included promises to honor legacies, not erase them.

New data shows a national drop in overdose deaths, but a closer look reveals a fractured reality with regional surges and a dangerous new drug cocktail.

Beyond the trade show floor, Chenwei Medical is executing a calculated strategy to fuse advanced critical care tech with deep clinical expertise in Latin America.

Biocytogen's new 'gold standard' accreditation isn't just about animal welfare. It's a calculated move to de-risk drug development and win global partners.

A new, single-shot vaccine for dogs targets two spreading diseases. This innovation aims to make vet visits less stressful and close critical health gaps.

At HLTH Europe, Saudi Arabia's KFSH revealed more than just a radiology AI. It unveiled a full ecosystem, proving how integrated tech transforms patient care.

As Southeast Asia races to become an EV powerhouse, the real challenge lies on the factory floor. A new wave of traceable assembly tech aims to solve it.

U.S. hospitals waste billions in usable medication each year. A new partnership shows how AI and a digital marketplace can plug the leak, a crucial move in an era of drug shortages.

Cincinnati's baseball team partners with Avocados From Peru in a strategic play that goes beyond the ballpark, blending experiential marketing with healthy eating.

Australian biotech Gelteq has a gel that makes bitter medicine taste good to dogs. It's more than a pet owner's dream—it's a strategic move in a $47B market.

A Chicago jury's landmark verdict reveals how a single day's delay can lead to a lifetime of paralysis, questioning the very fabric of patient safety.

A landmark deal for CEL-SCI’s cancer drug Multikine in Saudi Arabia isn't just about a new market; it’s a case study in national ambition and biotech finance.

The Anne Frank Center USA is taking Holocaust education to TikTok and Instagram, battling misinformation where it thrives. Can short-form video win this fight?

With Bill C-34, Canada wants to make social media and AI safer for children. But can it balance protection with privacy and digital freedom?

With a new CMO, Get A Drip is capitalizing on the longevity trend. But as it expands, it faces questions on scientific rigor and regulatory oversight.

Leveraged finance titans turned a personal fight into a philanthropic powerhouse, raising a record $4.3M to fund the science that’s turning the tide on melanoma.

The Jim Henson Company's 'Monster Dance' uses cutting-edge tech and creative choreography to teach kids emotional literacy. It's more than a show; it's a new paradigm.